- Home
- COLL vs NG Comparison
COLL vs NG Comparison
Compare COLL & NG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- NG
- Stock Information
- Founded
- COLL 2002
- NG 1984
- Country
- COLL United States
- NG Canada
- Employees
- COLL N/A
- NG N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- NG Precious Metals
- Sector
- COLL Health Care
- NG Basic Materials
- Exchange
- COLL Nasdaq
- NG Nasdaq
- Market Cap
- COLL 1.1B
- NG 1.2B
- IPO Year
- COLL 2015
- NG N/A
- Fundamental
- Price
- COLL $29.58
- NG $3.40
- Analyst Decision
- COLL Strong Buy
- NG
- Analyst Count
- COLL 6
- NG 0
- Target Price
- COLL $42.00
- NG N/A
- AVG Volume (30 Days)
- COLL 440.1K
- NG 1.3M
- Earning Date
- COLL 11-07-2024
- NG 10-02-2024
- Dividend Yield
- COLL N/A
- NG N/A
- EPS Growth
- COLL 757.11
- NG N/A
- EPS
- COLL 2.16
- NG N/A
- Revenue
- COLL $599,245,000.00
- NG N/A
- Revenue This Year
- COLL $13.02
- NG N/A
- Revenue Next Year
- COLL $18.01
- NG N/A
- P/E Ratio
- COLL $13.68
- NG N/A
- Revenue Growth
- COLL 9.62
- NG N/A
- 52 Week Low
- COLL $25.07
- NG $2.23
- 52 Week High
- COLL $42.29
- NG $4.88
- Technical
- Relative Strength Index (RSI)
- COLL 26.96
- NG 41.98
- Support Level
- COLL $29.69
- NG $3.26
- Resistance Level
- COLL $35.62
- NG $3.41
- Average True Range (ATR)
- COLL 1.41
- NG 0.16
- MACD
- COLL -0.39
- NG 0.00
- Stochastic Oscillator
- COLL 6.36
- NG 27.19
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About NG Novagold Resources Inc.
Novagold Resources Inc is a mineral exploration company engaged in the exploration and development of mineral properties. The company owns 50% of the Donlin Gold project, which is located in southwestern Alaska, approximately 20 kilometers north of the village of Crooked Creek on the Kuskokwim River.